Wenzel K W
Praxis für Innere Krankheiten, Endokrinologie, Nuklearmedizin, Freie Universität Berlin, BRD.
Acta Med Austriaca. 1991;18(1):1-6.
The recognition of the peripheral state of thyroid hormones is often disturbed by factors like pharmacological interferences or non-thyroidal illness, especially borderline hyperthyroidism may often be misjudged. Some serological parameters like the measurement of sex hormone binding globulin, precollagen-peptid I and III, osteocalcin, angiotensin converting enzyme and fibronectin are often elevated in such states and can indicate thyrotoxicosis of certain tissues. Such thyrotoxicosis-like alterations can be shown also in TSH-suppressive therapy with levothyroxine. In contrast to early publications there is obviously only a minor influence of levothyroxine treatment on bone metabolism, where a decrease of bone mass is less probable. Recent developments of sensitive and specific modifications in estimating antibodies against thyroidal peroxydase in recognizing thyroid autoimmune disease and of thyroglobulin in the follow-up of differentiated thyroid cancer are becoming important tools in clinical medicine.
甲状腺激素外周状态的识别常受到药物干扰或非甲状腺疾病等因素的影响,尤其是边缘性甲状腺功能亢进症常常可能被误诊。在这种情况下,一些血清学参数,如性激素结合球蛋白、前胶原肽I和III、骨钙素、血管紧张素转换酶和纤连蛋白的测定值常常升高,并且可以提示某些组织的甲状腺毒症。这种类似甲状腺毒症的改变在左甲状腺素抑制治疗中也可以出现。与早期出版物不同的是,显然左甲状腺素治疗对骨代谢的影响很小,骨量减少的可能性较小。在识别甲状腺自身免疫性疾病时,针对甲状腺过氧化物酶抗体估计以及在分化型甲状腺癌随访中针对甲状腺球蛋白的敏感和特异检测方法的最新进展正成为临床医学中的重要工具。